Biotechnology American Journal of Psychiatry Publishes Data From Alkermes’ Phase 3 ENLIGHTEN-2 Weight Study of ALKS 3831 in Patients With Schizophrenia August 17, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reata Pharmaceuticals, Inc. - RETA August 16, 2020
Biotechnology Ascendis Pharma A/S Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 27 August 13, 2020
Biotechnology European Medicines Agency Validates BioMarin’s Marketing Authorization Application for Vosoritide to Treat Children with Achondroplasia August 13, 2020
Search
